Systemic reactions:
Saved in:
| Format: | Book |
|---|---|
| Language: | English |
| Published: |
Philadelphia u.a.
Saunders
1995
|
| Series: | Immunology and allergy clinics of North America
15,3 |
| Subjects: | |
| Online Access: | Inhaltsverzeichnis |
| Physical Description: | VIII S., S. 447 - 640 |
Staff View
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV010406512 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 951004s1995 |||| 00||| eng d | ||
| 035 | |a (OCoLC)33066937 | ||
| 035 | |a (DE-599)BVBBV010406512 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-12 |a DE-29 | ||
| 050 | 0 | |a RD82.7.A48 | |
| 084 | |a XD 2800 |0 (DE-625)152549:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Systemic reactions |c Frank S. Virant, guest ed. |
| 264 | 1 | |a Philadelphia u.a. |b Saunders |c 1995 | |
| 300 | |a VIII S., S. 447 - 640 | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Immunology and allergy clinics of North America |v 15,3 | |
| 650 | 7 | |a Anafylaxie |2 gtt | |
| 650 | 2 | |a Anaphylaxie - induit chimiquement | |
| 650 | 2 | |a Anaphylaxie - étiologie | |
| 650 | 4 | |a Anaphylaxis | |
| 650 | 4 | |a Anaphylaxis |x chemically induced | |
| 650 | 4 | |a Anaphylaxis |x etiology | |
| 650 | 0 | 7 | |a Anaphylaxie |0 (DE-588)4001886-6 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Anaphylaxie |0 (DE-588)4001886-6 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Virant, Frank S. |e Sonstige |4 oth | |
| 830 | 0 | |a Immunology and allergy clinics of North America |v 15,3 |w (DE-604)BV000645505 |9 15,3 | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006929875&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-006929875 | ||
Record in the Search Index
| _version_ | 1804124834137899008 |
|---|---|
| adam_text | SVSIHMIC: REACTIONS
CONTENTS
Preface xi
Frank S. Virant
Anaphylaxis 447
Stephen L. Winbery and Philip L. Lieberman
The incidence of anaphylaxis and anaphylactoid reactions is in¬
creasing. Many reactions may be iatrogenic. Anaphylactic reac¬
tions are potentially lethal but can usually be treated successfully
if the diagnosis is made in a timely manner. The differential
diagnosis for anaphylaxis can be pursued largely on the basis of
a detailed history and clinical assessment.
Foods 477
John M. James and A. Wesley Burks
Severe anaphylactic reactions including fatalities can occur fol¬
lowing the ingestion of food. Specific food allergens, such as
peanut, milk, egg, and tree nuts, have been implicated in these
reactions, the majority of which are believed to be the result of
classic hypersensitivity mechanisms. Common features in re¬
ported cases include previous episodes of anaphylaxis with the
incriminated foods, a failure to recognize early symptoms of
anaphylaxis, and a delay or lack .of immediate use of subcu¬
taneous epinephrine to treat these systemic, allergic reactions.
Food induced anaphylaxis can be minimized by diligent allergen
avoidance measures, a greater attention to the severity of clinical
symptoms, and specific patient educations measures concerning
food allergy. The prompt, judicious administration of epinephrine
in suspected cases of anaphylaxis from food ingestion should be
emphasized.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
VOLUME 15 • NUMBER 3 • AUGUST 1995 V
Food and Drug Additives 489
Ronald A. Simon
Topics discussed in this article include general considerations and
descriptions of food and drug additives; urticaria, angioedema,
anaphylaxis, and additives; and asthma and additives.
Aspirin and Nonsteroidal Anti Inflammatory Drugs 529
Donald D. Stevenson
Adverse reactions to aspirin (ASA) and nonsteroidal anti in¬
flammatory drugs (NSAIDs) have been recognized for many
years. Systemic or generalized reactions to ASA/NSAIDs include
(1) acute respiratory reactions, characterized by nasal mucosal
swelling, laryngeal spasm, and bronchospasm; (2) initiation or
perpetuation of urticaria; and (3) anaphylaxis (anaphylactoid re¬
actions). Each of these systemic reactions presents with different
clinical patterns, target organ responses, and mechanisms of ac¬
tion. This article focuses on the spectrum of reactions induced by
ASA and NSAIDs, the clinical settings in which these reactions
occur, as well as current insights into pathogenesis and manage¬
ment strategies that might be helpful to practicing physicians.
Vaccinations 553
Roger H. Kobayashi
Vaccinations have prevented the occurrence of serious illnesses
and death. Millions of lives have been saved and countless other
millions have been spared sickness and debilitation. These bene¬
fits do not come without some costs, however. Reactions do occur
following immunization, and some are quite serious, such as
anaphylaxis, encephalitis, febrile seizures, and (rarely) dissemina¬
tion and death from the immunizing agent. The diphtheria, per¬
tussis, and tetanus (DPT) and measles mumps rubella (MMR)
vaccines have caused the greatest concern in industrialized coun¬
tries, although systemic reactions can occur with varicella, influ¬
enza, and other commonly used vaccines. Additionally, egg
based vaccines cause anaphylactic reactions in egg sensitive
individuals rarely.
Hymenoptera 567
Robert E. Reisman
Insect stings are a frequent cause of anaphylaxis. These reactions
are mediated by IgE antibodies reacting with venom components.
There are no reliable predictors to detect individuals at risk for
initial venom allergy. Anaphylactic symptoms vary from mild
manifestations such as urticaria and angioedema to severe reac¬
tions characterized by loss of consciousness, shock, upper airway
edema, and even death. Severe reactions may occur at any age but
are relatively more frequent in adults. Venom immunotherapy is
vi CONTENTS
extremely effective prophylaxis for people who have had prior
systemic sting reactions and demonstrate positive venom skin
tests.
Exercise 575
Frank S. Virant
Systemic reactions to exercise occur primarily in the form of
cholinergic urticaria or exercise anaphylaxis. The diagnosis can
typically be clarified on the basis of a careful history and physical
examination, including emphasis on precipitating events, urti¬
caria morphology, and the presence or absence of cardiovascular
collapse or bronchospasm. Rarely, passive heat or exercise chal¬
lenges may be necessary to confirm the diagnosis. Although med¬
ications are important for breakthrough attacks, the most effective
management of systemic reactions to exercise involves avoidance
of known precipitating triggers.
Natural Rubber Latex 583
John W. Yunginger
Anaphylaxis induced by natural rubber latex is being recognized
with increasing frequency. Health care workers and persons with
myelodysplasia are at increased risk of latex sensitization; con¬
comitant allergy to inhalants or foods is common. Accurate diag¬
nosis and latex avoidance, especially exposure to rubber gloves,
are required to prevent future reactions.
Radiocontrast 597
William H. Bush, Jr, and Dennis P. Swanson
Adverse effects of radiocontrast are relatively common, although
usually of a mild nature. Life threatening reactions can occur
with even the newer, lower osmolality, nonionic agents. The exact
cause(s) of these reactions remains controversial. Types of adverse
reactions, proposed causative mechanisms, related patient factors,
and an approach to preventing and treating these reactions are
reviewed.
Local Anesthetics and Neuromuscular Blocking Agents 613
David L. Smith and Richard D. deShazo
Anaphylactic or anaphylactoid reactions to local anesthetics may
exist but are extremely rare. A practical, management approach
(provocative dose skin testing) using preservative and epineph
rine free local anesthetic preparations has been developed and is
detailed. Anaphylactic reactions to neuromuscular blockers have
been shown to be due to cross linking of IgE by these bivalent
compounds. A hypotensive reaction occurring after administra¬
tion of a neuromuscular blocker should be assumed to be due to
CONTENTS vii
anaphylaxis. Reactions to these agents can be predicted with
skin testing.
Index 635
Subscription Information Inside back cover
Viii CONTENTS
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV010406512 |
| callnumber-first | R - Medicine |
| callnumber-label | RD82 |
| callnumber-raw | RD82.7.A48 |
| callnumber-search | RD82.7.A48 |
| callnumber-sort | RD 282.7 A48 |
| callnumber-subject | RD - Surgery |
| classification_rvk | XD 2800 |
| ctrlnum | (OCoLC)33066937 (DE-599)BVBBV010406512 |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01598nam a2200421 cb4500</leader><controlfield tag="001">BV010406512</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">951004s1995 |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)33066937</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV010406512</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-29</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RD82.7.A48</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XD 2800</subfield><subfield code="0">(DE-625)152549:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Systemic reactions</subfield><subfield code="c">Frank S. Virant, guest ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Philadelphia u.a.</subfield><subfield code="b">Saunders</subfield><subfield code="c">1995</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VIII S., S. 447 - 640</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Immunology and allergy clinics of North America</subfield><subfield code="v">15,3</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Anafylaxie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Anaphylaxie - induit chimiquement</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Anaphylaxie - étiologie</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anaphylaxis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anaphylaxis</subfield><subfield code="x">chemically induced</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anaphylaxis</subfield><subfield code="x">etiology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Anaphylaxie</subfield><subfield code="0">(DE-588)4001886-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Anaphylaxie</subfield><subfield code="0">(DE-588)4001886-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Virant, Frank S.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Immunology and allergy clinics of North America</subfield><subfield code="v">15,3</subfield><subfield code="w">(DE-604)BV000645505</subfield><subfield code="9">15,3</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006929875&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-006929875</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV010406512 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T17:51:57Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-006929875 |
| oclc_num | 33066937 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-12 DE-29 |
| owner_facet | DE-355 DE-BY-UBR DE-12 DE-29 |
| physical | VIII S., S. 447 - 640 |
| publishDate | 1995 |
| publishDateSearch | 1995 |
| publishDateSort | 1995 |
| publisher | Saunders |
| record_format | marc |
| series | Immunology and allergy clinics of North America |
| series2 | Immunology and allergy clinics of North America |
| spelling | Systemic reactions Frank S. Virant, guest ed. Philadelphia u.a. Saunders 1995 VIII S., S. 447 - 640 txt rdacontent n rdamedia nc rdacarrier Immunology and allergy clinics of North America 15,3 Anafylaxie gtt Anaphylaxie - induit chimiquement Anaphylaxie - étiologie Anaphylaxis Anaphylaxis chemically induced Anaphylaxis etiology Anaphylaxie (DE-588)4001886-6 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Anaphylaxie (DE-588)4001886-6 s DE-604 Virant, Frank S. Sonstige oth Immunology and allergy clinics of North America 15,3 (DE-604)BV000645505 15,3 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006929875&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Systemic reactions Immunology and allergy clinics of North America Anafylaxie gtt Anaphylaxie - induit chimiquement Anaphylaxie - étiologie Anaphylaxis Anaphylaxis chemically induced Anaphylaxis etiology Anaphylaxie (DE-588)4001886-6 gnd |
| subject_GND | (DE-588)4001886-6 (DE-588)4143413-4 |
| title | Systemic reactions |
| title_auth | Systemic reactions |
| title_exact_search | Systemic reactions |
| title_full | Systemic reactions Frank S. Virant, guest ed. |
| title_fullStr | Systemic reactions Frank S. Virant, guest ed. |
| title_full_unstemmed | Systemic reactions Frank S. Virant, guest ed. |
| title_short | Systemic reactions |
| title_sort | systemic reactions |
| topic | Anafylaxie gtt Anaphylaxie - induit chimiquement Anaphylaxie - étiologie Anaphylaxis Anaphylaxis chemically induced Anaphylaxis etiology Anaphylaxie (DE-588)4001886-6 gnd |
| topic_facet | Anafylaxie Anaphylaxie - induit chimiquement Anaphylaxie - étiologie Anaphylaxis Anaphylaxis chemically induced Anaphylaxis etiology Anaphylaxie Aufsatzsammlung |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=006929875&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV000645505 |
| work_keys_str_mv | AT virantfranks systemicreactions |